调节性T细胞与促炎细胞因子在子宫内膜异位症微环境中协同促进血管生成
该体外研究用原代子宫内膜间质细胞、单核细胞、调节性T细胞及人脐静脉内皮细胞,发现CCL17与CCL22招募调节性T细胞并上调其免疫抑制,调节性T细胞来源TGF-β1与促炎细胞因子经p38/ERK1/2通路协同促进IL-8与VEGF表达及血管生成,作者认为共同靶向调节性T细胞与促炎细胞因子可能有效。
要点
- 子宫内膜间质细胞与单核细胞共培养产生高水平CCL22与CCL17,雌二醇或孕酮进一步促进并增强对调节性T细胞的趋化。
- 调节性T细胞来源TGF-β1与促炎细胞因子经p38/ERK1/2通路协同促进间质细胞IL-8与VEGF表达。
- 作者认为共同靶向调节性T细胞与促炎细胞因子可能成为子宫内膜异位症的有效治疗。
核心结论
- 高水平的CCL17和CCL22招募调节性T细胞并上调其免疫抑制,进而可能与促炎细胞因子协同促进子宫内膜细胞的血管生成。
- 作者认为共同靶向调节性T细胞和促炎细胞因子可能是子宫内膜异位症的有效治疗。
研究设计与样本
- 研究使用原代人类子宫内膜间质细胞、单核细胞、调节性T细胞和人脐静脉内皮细胞进行体外实验,所有实验至少重复三次。
- 采用Transwell迁移实验评估调节性T细胞迁移,用In-Cell Western和传统western blot检测ERK1/2、c-Jun N端激酶和p38信号通路活化。
- 用ELISA检测培养上清中CCL22、CCL17、TGF-β1、IL-1β、TNF-α、IL-8和VEGF表达变化,用多色流式细胞术分析调节性T细胞CCR4、CD4、CD25、Foxp3、CTLA-4、CD39和CD73表达。
主要发现
- 子宫内膜间质细胞与单核细胞共培养产生的CCL22和CCL17水平显著高于单独培养的间质细胞或单核细胞,雌二醇或孕酮进一步促进该上调并对调节性T细胞显示更强趋化作用。
- 间质细胞与单核细胞共培养刺激调节性T细胞分泌TGF-β1,该作用可被抗CCL22和/或抗CCL17中和抗体抑制。
- 调节性T细胞CCR4表达在间质细胞-单核细胞共培养中上调,尤其经雌二醇和/或孕酮处理,该效应可被抗CCL22和/或抗CCL17中和抗体消除。
- 经雌二醇(10^-8 mol/l)和孕酮(10^-8 mol/l)处理的调节性T细胞-间质细胞-单核细胞共培养增强调节性T细胞免疫抑制,表现为Foxp3、CTLA-4、CD39和CD73表达升高。
- 间质细胞-单核细胞共培养显著促进IL-1β和TNF-α分泌;调节性T细胞来源TGF-β1激活间质细胞p38/ERK1/2通路,IL-1β和TNF-α与TGF-β1具协同作用,协同促进间质细胞IL-8和VEGF表达,高水平IL-8和VEGF刺激人脐静脉内皮细胞血管生成。
局限性
- 本研究仅在体外使用子宫内膜异位症患者的在位子宫内膜间质细胞而非异位细胞进行。
- 因此有必要进一步实验以确定调节性T细胞是否在体内与促炎细胞因子协同促进子宫内膜异位症微环境中的血管生成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do regulatory T cells (Tregs) contribute to angiogenesis in endometriosis? SUMMARY ANSWER: High levels of CCL17 and CCL22 cause the recruitment of Tregs, upregulate the immunosuppression of Tregs and, in turn, may promote angiogenesis in endometrial cells in synergy with proinflammatory cytokines. WHAT IS ALREADY KNOWN: The peritoneal fluid of patients with endometriosis has a higher percentage of Tregs than that of normal individuals; however, the regulatory role of Tregs in the disease remains unclear. STUDY DESIGN, SIZE, DURATION: This study used primary human endometrial stromal cells (ESCs), monocytes (Mo), Tregs and human umbilical vein endothelial cells (HUVECs). All experiments were performed at least three times. PARTICIPANTS/MATERIALS, SETTING, METHODS: The migration of Tregs was evaluated by the transwell migration assay. The activation of extracellular signal-regulated kinase (ERK)1/2, c-Jun N-terminal kinase and p38 signaling pathways was examined using the In-Cell WesternTM (LI-COR®) western blot analysis system, as well as by traditional western blot analysis. Changes in the expression of CCL22, CCL17, transforming growth factor-beta 1 (TGF-β1), Interleukin (IL)-1β, tumor necrosis factor alpha (TNF-α), IL-8 and vascular endothelial growth factor (VEGF) in cell-culture supernatant were detected by ELISA. We analyzed the Tregs by multicolor flow cytometry to directly test the expression of CCR4, CD4, CD25, Foxp3, CTLA-4, CD39 and CD73. MAIN RESULTS AND THE ROLE OF CHANCE: Our results showed that ESCs-Mo co-culture produced significantly higher levels of CCL22 and CCL17 than ESCs or Mo cultured alone, and that estradiol (E2) or progesterone (P) further promoted this upregulation, demonstrating stronger chemotaxis on Tregs. The co-culture of ESCs with Mo stimulated TGF-β1 secretion by Tregs, which could be inhibited by anti-CCL22 or/and anti-CCL17 neutralizing antibodies (Abs). The expression of CCR4 by Tregs was upregulated in ESCs-Mo co-culture, especially by treatment with E2 and/or P, and this effect could be abolished by anti-CCL22 and/or anti-CCL17-neutralizing Abs. The Treg-ESCs-Mo co-culture treated with E2 (10-8 mol/l) and P (10-8 mol/l) could enhance the immunosuppression of Tregs, as proved by the elevated expression of Foxp3, CTLA-4, CD39 and CD73 on Tregs. ESCs-Mo co-culture could significantly promote the secretion of IL-1β and TNF-α. TGF-β1 from Tregs could activate p38/ERK1/2 signaling pathways in ESCs, and IL-1β and TNF-α produced by ESCs-Mo co-culture had synergistic roles with TGF-β1. TGF-β1 and the proinflammatory cytokines IL-1β or TNF-α could synergistically promote IL-8 and VEGF expression in ESCs via the p38/ERK1/2 signaling pathways. The high levels of IL-8 and VEGF in the supernatant of ESCs stimulated the angiogenesis of HUVECs. LARGE SCALE DATA: None. LIMITATIONS, REASONS FOR CAUTION: This study was only performed in vitro using eutopic ESCs, instead of ectopic cells, from endometriosis patients. Therefore, it is necessary to do further experiments to determine whether Tregs promote angiogenesis in the endometriotic milieu in synergy with proinflammatory cytokines in vivo. WIDER IMPLICATIONS OF THE FINDINGS: Co-targeting Tregs and proinflammatory cytokines may be an effective treatment for endometriosis. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by Ministry of Science and Technology of China 2015CB943300 to L.D.-J.; National Natural Science Foundation of China, item number 81200425 to W.X.-Q.; National Natural Science Foundation of China, item number 81471548 to L.D.-J.; and The Research Fund for the Doctoral Program of Higher Education of China to W.X.-Q. (20110071120093). The authors have no conflicts of interest to declare.
引用
- Wang XQ, Zhou WJ, Luo XZ, et al. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu. Hum Reprod. 2017. PMID: 28383711. doi:10.1093/humrep/dex067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。